BioCentury
ARTICLE | Company News

H. Lee Moffitt Cancer Center, Aptose Biosciences deal

November 23, 2015 8:00 AM UTC

Moffitt Cancer Center granted Aptose exclusive, worldwide rights to develop and commercialize preclinical, small molecule dual BET bromodomain protein and kinase inhibitors to treat hematologic malign...